Skip to main content
. 2021 Dec 9;11:762946. doi: 10.3389/fonc.2021.762946

Figure 6.

Figure 6

NR2C2 could act as a tumor-suppressor gene in bladder cancer based on TCGA and GTEx database. (A) Expression of miR-616-5p in bladder cancer tissues and adjacent normal tissues based on The Cancer Genome Atlas and GTEx databases. (B) Overall survival curve shows that a higher NR2C2 expression correlates with better prognosis in bladder cancer patients.